0001209191-17-026471.txt : 20170410
0001209191-17-026471.hdr.sgml : 20170410
20170410214303
ACCESSION NUMBER: 0001209191-17-026471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170406
FILED AS OF DATE: 20170410
DATE AS OF CHANGE: 20170410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUGGAN ROBERT W
CENTRAL INDEX KEY: 0001055919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17754790
MAIL ADDRESS:
STREET 1: 611 SOUTH FORT HARRISON AVE
STREET 2: SUITE 306
CITY: CLEARWATER
STATE: FL
ZIP: 33756
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-06
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001055919
DUGGAN ROBERT W
611 S. FORT HARRISON AVE., SUITE 306
CLEARWATER
FL
33756
0
0
1
0
Common Stock
2017-04-06
4
P
0
21200
18.54
A
2408686
D
Common Stock
2017-04-06
4
P
0
44200
19.703
A
2452886
D
Common Stock
2017-04-07
4
P
0
94100
19.594
A
2546986
D
Common Stock
2017-04-10
4
P
0
9200
20.375
A
2556186
D
Common Stock
2017-04-10
4
P
0
22764
21.397
A
2578950
D
This is the weighted average purchase price of the shares, which ranged from $18.122 to $18.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Includes 9,000 shares purchased by the Reporting Person that were inadvertently omitted from previous reports.
This is the weighted average purchase price of the shares, which ranged from $19.125 to $19.976 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $19.079 to $20.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $20.05 to $20.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $21.13 to $21.616 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Brian Dow, as Attorney-in-Fact for Robert W. Duggan
2017-04-10